perflubron has been researched along with EHS Tumor in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adams, G; Counsell, C; Sansom, J; Stratford, I; Thomas, C; Wood, P | 1 |
Ara, G; Ha, C; Herman, TS; Holden, SA; Teicher, BA | 1 |
2 other study(ies) available for perflubron and EHS Tumor
Article | Year |
---|---|
The perfluorocarbon emulsion PFOB: potential indicator of change in blood volume using fluorine-19 NMR spectroscopy.
Topics: Animals; Blood Volume; Carcinoma, Squamous Cell; Contrast Media; Fluorocarbons; Hydralazine; Hydrocarbons, Brominated; Magnetic Resonance Spectroscopy; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Regional Blood Flow; Sarcoma, Experimental; Xenon Radioisotopes | 1992 |
Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents.
Topics: Alkylating Agents; Animals; Blood Substitutes; Carbon Dioxide; Combined Modality Therapy; Emulsions; Fluorocarbons; Hydrocarbons, Brominated; Male; Mice; Mice, Inbred C3H; Oxygen; Sarcoma, Experimental | 1992 |